Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ceftazidime (fortaz) (1 trial)
domperidone (1 trial)
glucose (1 trial)
sulbactam (unasyn) (1 trial)
nitric oxide (inomax) (1 trial)
Bronchopulmonary Dysplasia (Phase 3)
Premature Birth (Phase 4)
Trials (2 total)
Trial APIs (5 total)